Previously it has been reported that impeding the expression of NF-κB could result in the instigation of apoptotic cell death in different cancer cells with a concomitant reduction in the invasive potential and proliferation of cancer cells, resulting in an enhanced sensitivity towards chemotherapeutics [18,19,20]. This evidence concerns the gene NFKB1 and cancer.